Cargando…
Postvaccinal Encephalitis after ChAdOx1 nCov‐19
The global SARS‐CoV‐2 pandemic has contributed to more than 163 million confirmed infections and 3.3 million deaths worldwide. The severity of the pandemic has led to an unprecedented effort to develop multiple effective vaccines. Due to excellent safety and efficacy data from clinical trials, sever...
Autores principales: | Zuhorn, Frédéric, Graf, Tilmann, Klingebiel, Randolf, Schäbitz, Wolf‐Rüdiger, Rogalewski, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426979/ https://www.ncbi.nlm.nih.gov/pubmed/34324214 http://dx.doi.org/10.1002/ana.26182 |
Ejemplares similares
-
Seltene Enzephalitis nach Impfung gegen SARS-CoV-2
por: Zuhorn, Frédéric, et al.
Publicado: (2021) -
Postvaccinal GABA‐B receptor antibody encephalitis after ChAdOx1 nCoV‐19 vaccination
por: Ahn, Seon‐Jae, et al.
Publicado: (2022) -
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Rogalewski, Andreas, et al.
Publicado: (2007) -
Parainfectious encephalitis in COVID-19: “The Claustrum Sign”
por: Zuhorn, Frédéric, et al.
Publicado: (2020) -
Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination
por: Hyun, Hakjun, et al.
Publicado: (2021)